MPS Pharmaa Limited, formerly Advik Laboratories Limited, will close its trading window for directors, promoters, key managerial personnel, other designated persons/employees and their immediate relatives from October 1, 2026, until 48 hours after the unaudited financial results for the quarter and half year ending September 30, 2026, are made public, according to a filing with the BSE Limited.